A detailed history of Financial Network Wealth Advisors LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Financial Network Wealth Advisors LLC holds 28 shares of HALO stock, worth $1,320. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28
Previous 28 -0.0%
Holding current value
$1,320
Previous $1.47 Million 9.35%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$37.81 - $52.4 $1,058 - $1,467
28 New
28 $1.47 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.57B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Financial Network Wealth Advisors LLC Portfolio

Follow Financial Network Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Network Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Network Wealth Advisors LLC with notifications on news.